175 related articles for article (PubMed ID: 35622982)
1. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
[TBL] [Abstract][Full Text] [Related]
3. Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients.
Wang Y; Huang Q; He F
J Clin Lab Anal; 2022 Apr; 36(4):e24331. PubMed ID: 35262976
[TBL] [Abstract][Full Text] [Related]
4. Serum PCSK9 is positively correlated with disease activity and Th17 cells, while its short-term decline during treatment reflects desirable outcomes in ankylosing spondylitis patients.
Cai J; Jiang Y; Chen F; Wu S; Ren H; Wang P; Wang J; Liu W
Ir J Med Sci; 2023 Aug; 192(4):1785-1791. PubMed ID: 36344709
[TBL] [Abstract][Full Text] [Related]
5. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
Ye Z; Chen L; Fang Y; Zhao L
J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
[TBL] [Abstract][Full Text] [Related]
6. MALT1 regulates Th2 and Th17 differentiation
Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
Front Immunol; 2022; 13():913830. PubMed ID: 35967391
[TBL] [Abstract][Full Text] [Related]
7. Blood HDAC4 Variation Links With Disease Activity and Response to Tumor Necrosis Factor Inhibitor and Regulates CD4+ T Cell Differentiation in Ankylosing Spondylitis.
Dou B; Ma F; Jiang Z; Zhao L
Front Med (Lausanne); 2022; 9():875341. PubMed ID: 35602496
[TBL] [Abstract][Full Text] [Related]
8. PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis.
Zhang Q; Jin D; Mou X; Ye H
J Clin Lab Anal; 2022 Mar; 36(3):e24267. PubMed ID: 35104386
[TBL] [Abstract][Full Text] [Related]
9. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis.
Li M; Zhou X
Inflammopharmacology; 2021 Oct; 29(5):1371-1378. PubMed ID: 34406596
[TBL] [Abstract][Full Text] [Related]
11. MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
Dong X; Chen X; Ren Y
J Clin Lab Anal; 2022 Oct; 36(10):e24650. PubMed ID: 36036788
[TBL] [Abstract][Full Text] [Related]
12. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation.
Liu L; Gao Y; Si Y; Liu B; Liu X; Li G; Wang R
J Clin Lab Anal; 2022 May; 36(5):e24379. PubMed ID: 35353938
[TBL] [Abstract][Full Text] [Related]
13. JKAP serves as a potential biomarker for the evaluation of inflammatory condition, disease activity, and treatment response to TNF inhibitor in ankylosing spondylitis patients.
Zhou X; Li M
Mod Rheumatol; 2022 Apr; 32(3):613-618. PubMed ID: 34918117
[TBL] [Abstract][Full Text] [Related]
14. MALT1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
[TBL] [Abstract][Full Text] [Related]
15. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
Wu Z; Bi Y
J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal variation of serum PCSK9 in ulcerative colitis: association with disease activity, T helper 1/2/17 cells, and clinical response of tumor necrosis factor inhibitor.
Deng J; Jiang Y; Luan L; Fu S; Huang M; Dai Z; Liao Y; Guo S; Fu Y
Ir J Med Sci; 2024 Feb; 193(1):165-172. PubMed ID: 37420045
[TBL] [Abstract][Full Text] [Related]
17. Linkage of Blood MALT1 with CD4+ T Cell Subset, Inflammation, Lipid, and Its Potency as a Biomarker for Predicting Major Adverse Cardiovascular Events in Coronary Heart Disease Patients.
Zhang L; Li J; Yang Z; Wang S; Liu J; Luan S; Tian G
Ann Clin Lab Sci; 2023 Jul; 53(4):507-515. PubMed ID: 37625844
[TBL] [Abstract][Full Text] [Related]
18. Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis.
Sun Z; Zhang Y; Zhou H; Li J; Zhou Y; Wang L
Scand J Clin Lab Invest; 2023 Dec; 83(8):540-547. PubMed ID: 38156824
[TBL] [Abstract][Full Text] [Related]
19. Predictive Values of Blood Type I and Type II Interferon Production for Disease Activity and Clinical Response to TNF-α Blocking Therapy in Patients with Ankylosing Spondylitis.
Hu Y; Lou B; Jiang Z; Yu C
Tohoku J Exp Med; 2023 Jul; 260(3):263-271. PubMed ID: 37081619
[TBL] [Abstract][Full Text] [Related]
20. PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor-κB pathway in ankylosing spondylitis.
Cai J; Jiang Y; Chen F; Wu S; Ren H; Wang P; Wang J; Liu W
Immun Inflamm Dis; 2023 May; 11(5):e870. PubMed ID: 37249282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
